The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 22, 2016

Filed:

May. 05, 2010
Applicants:

Frank Osterroth, Dietzenbach, DE;

Christoph Uherek, Seligenstadt, DE;

Christoph Bruecher, Eschborn, DE;

Benjamin Daelken, Frankfurt am Main, DE;

Andre Engling, Frankfurt, DE;

Thomas Haeder, Dreieichenhain, DE;

Andrea Wartenberg-demand, Linden, DE;

Gabriele Niemann, Karlsruhe, DE;

Chantal Zuber, Frankfurt, DE;

Niklas Czeloth, Dreieich, DE;

Silke Aigner, Frankenthal, DE;

Steffen Zeng, Muenster, DE;

Gregor Schulz, Umkirch, DE;

Inventors:

Frank Osterroth, Dietzenbach, DE;

Christoph Uherek, Seligenstadt, DE;

Christoph Bruecher, Eschborn, DE;

Benjamin Daelken, Frankfurt am Main, DE;

Andre Engling, Frankfurt, DE;

Thomas Haeder, Dreieichenhain, DE;

Andrea Wartenberg-Demand, Linden, DE;

Gabriele Niemann, Karlsruhe, DE;

Chantal Zuber, Frankfurt, DE;

Niklas Czeloth, Dreieich, DE;

Silke Aigner, Frankenthal, DE;

Steffen Zeng, Muenster, DE;

Gregor Schulz, Umkirch, DE;

Assignees:

Biotest AG, Dreieich, DE;

Immunogen Inc., Waltham, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 47/48 (2006.01); B82Y 5/00 (2011.01);
U.S. Cl.
CPC ...
A61K 47/48276 (2013.01); A61K 47/48346 (2013.01); A61K 47/48569 (2013.01); B82Y 5/00 (2013.01);
Abstract

Disclosed are methods and treatment regimes that include the administration of immunconjugates targeting CD138 to combat diseases. The immunoconjugate is either used as the sole active ingredient, as part of a treatment regime or as part of an anticancer combination.


Find Patent Forward Citations

Loading…